Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count
The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV‐1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV‐1 subtype C infect...
Saved in:
Published in: | Journal of medical virology Vol. 78; no. 2; pp. 161 - 168 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-02-2006
Wiley-Liss |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV‐1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV‐1 subtype C infected, untreated Ethiopians followed twice yearly over a period of up to 5 years. The ExaVir Load test, version 1, was used for isolation and quantitation of HIV‐1 RT in plasma. The RT activities recovered were compared to the HIV‐1 RNA copy numbers, which had been determined previously by the NucliSens HIV‐1 QT Test. There was a significant correlation between the data obtained in the two tests (r = 0.65, P < 0.0001). During follow‐up, the median RT and RNA levels increased more or less in parallel up to approximately four times the values at admittance. CD4 cell counts, which had also been determined previously, decreased slowly but continuously from approximately 310 to 190 CD4 cells/ml. In the majority of individual patients, there was an inverse correlation between CD4 T‐cell counts and RT activity, and with the RNA copy number, and the data obtained by either test could be used to predict CD4 T‐cell counts. The ExaVir Load test thus provides data equivalent to the estimation of the number of HIV‐1 RNA copies for the prediction of CD4 T‐cell counts. It is based on a simple technique, can be run in any routine diagnostic laboratory, and is a competitive alternative for use in resource limited settings. J. Med. Virol. 78:161–168, 2006. © 2005 Wiley‐Liss, Inc. |
---|---|
AbstractList | The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV-1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV-1 subtype C infected, untreated Ethiopians followed twice yearly over a period of up to 5 years. The ExaVir Load test, version 1, was used for isolation and quantitation of HIV-1 RT in plasma. The RT activities recovered were compared to the HIV-1 RNA copy numbers, which had been determined previously by the NucliSens HIV-1 QT Test. There was a significant correlation between the data obtained in the two tests (r = 0.65, P < 0.0001). During follow-up, the median RT and RNA levels increased more or less in parallel up to approximately four times the values at admittance. CD4 cell counts, which had also been determined previously, decreased slowly but continuously from approximately 310 to 190 CD4 cells/ml. In the majority of individual patients, there was an inverse correlation between CD4 T-cell counts and RT activity, and with the RNA copy number, and the data obtained by either test could be used to predict CD4 T-cell counts. The ExaVir Load test thus provides data equivalent to the estimation of the number of HIV-1 RNA copies for the prediction of CD4 T-cell counts. It is based on a simple technique, can be run in any routine diagnostic laboratory, and is a competitive alternative for use in resource limited settings. The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV-1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV-1 subtype C infected, untreated Ethiopians followed twice yearly over a period of up to 5 years. The ExaVir Load test, version 1, was used for isolation and quantitation of HIV-1 RT in plasma. The RT activities recovered were compared to the HIV-1 RNA copy numbers, which had been determined previously by the NucliSens HIV-1 QT Test. There was a significant correlation between the data obtained in the two tests (r = 0.65, P < 0.0001). During follow-up, the median RT and RNA levels increased more or less in parallel up to approximately four times the values at admittance. CD4 cell counts, which had also been determined previously, decreased slowly but continuously from approximately 310 to 190 CD4 cells/ml. In the majority of individual patients, there was an inverse correlation between CD4 T-cell counts and RT activity, and with the RNA copy number, and the data obtained by either test could be used to predict CD4 T-cell counts. The ExaVir Load test thus provides data equivalent to the estimation of the number of HIV-1 RNA copies for the prediction of CD4 T-cell counts. It is based on a simple technique, can be run in any routine diagnostic laboratory, and is a competitive alternative for use in resource limited settings. The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV‐1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV‐1 subtype C infected, untreated Ethiopians followed twice yearly over a period of up to 5 years. The ExaVir Load test, version 1, was used for isolation and quantitation of HIV‐1 RT in plasma. The RT activities recovered were compared to the HIV‐1 RNA copy numbers, which had been determined previously by the NucliSens HIV‐1 QT Test. There was a significant correlation between the data obtained in the two tests (r = 0.65, P < 0.0001). During follow‐up, the median RT and RNA levels increased more or less in parallel up to approximately four times the values at admittance. CD4 cell counts, which had also been determined previously, decreased slowly but continuously from approximately 310 to 190 CD4 cells/ml. In the majority of individual patients, there was an inverse correlation between CD4 T‐cell counts and RT activity, and with the RNA copy number, and the data obtained by either test could be used to predict CD4 T‐cell counts. The ExaVir Load test thus provides data equivalent to the estimation of the number of HIV‐1 RNA copies for the prediction of CD4 T‐cell counts. It is based on a simple technique, can be run in any routine diagnostic laboratory, and is a competitive alternative for use in resource limited settings. J. Med. Virol. 78:161–168, 2006. © 2005 Wiley‐Liss, Inc. The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV-1 RNA based assay, and relates these data to the dynamics of CD4 cell counts. The samples examined originate from a prospective study of HIV-1 subtype C infected, untreated Ethiopians followed twice yearly over a period of up to 5 years. The ExaVir Load test, version 1, was used for isolation and quantitation of HIV-1 RT in plasma. The RT activities recovered were compared to the HIV-1 RNA copy numbers, which had been determined previously by the NucliSens HIV-1 QT Test. There was a significant correlation between the data obtained in the two tests (r=0.65, P<0.0001). During follow-up, the median RT and RNA levels increased more or less in parallel up to approximately four times the values at admittance. CD4 cell counts, which had also been determined previously, decreased slowly but continuously from approximately 310 to 190 CD4 cells/ml. In the majority of individual patients, there was an inverse correlation between CD4 T-cell counts and RT activity, and with the RNA copy number, and the data obtained by either test could be used to predict CD4 T-cell counts. The ExaVir Load test thus provides data equivalent to the estimation of the number of HIV-1 RNA copies for the prediction of CD4 T-cell counts. It is based on a simple technique, can be run in any routine diagnostic laboratory, and is a competitive alternative for use in resource limited settings. J. Med. Virol. 78:161-168, 2006. |
Author | Britton, Sven Malmsten, Anders Wolday, Dawit Girma, Mulu Meselle, Tsehaynesh Seyoum, Elizabeth Gronowitz, J. Simon |
Author_xml | – sequence: 1 givenname: Elizabeth surname: Seyoum fullname: Seyoum, Elizabeth organization: Ethio-Netherlands AIDS Research Project (ENARP), Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia – sequence: 2 givenname: Dawit surname: Wolday fullname: Wolday, Dawit organization: Ethio-Netherlands AIDS Research Project (ENARP), Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia – sequence: 3 givenname: Mulu surname: Girma fullname: Girma, Mulu organization: Ethio-Netherlands AIDS Research Project (ENARP), Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia – sequence: 4 givenname: Anders surname: Malmsten fullname: Malmsten, Anders organization: Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden – sequence: 5 givenname: Tsehaynesh surname: Meselle fullname: Meselle, Tsehaynesh organization: Ethio-Netherlands AIDS Research Project (ENARP), Ethiopian Health and Nutrition Research Institute (EHNRI), Addis Ababa, Ethiopia – sequence: 6 givenname: J. Simon surname: Gronowitz fullname: Gronowitz, J. Simon organization: Cavidi Tech AB, Uppsala Science Park, Uppsala, Sweden – sequence: 7 givenname: Sven surname: Britton fullname: Britton, Sven email: sven.britton@medks.ki.se organization: Karolinska Hospital, Karolinska Institute, Stockholm, Sweden |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17551119$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16372295$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:1932170$$DView record from Swedish Publication Index |
BookMark | eNqFkUtvEzEUhS1URNPAgj-AvAGJxbR-xPYMuyrQpigtUiiFneWZuSO5nVdtT0o2_HYcMm1WFSvb198519fnCB20XQsIvaXkmBLCTm6b9TEjgvEXaEJJJpOMKHqAJoTOZCIlFYfoyPtbQkiaMfYKHVLJFWOZmKA_K1iD84CDM60vnO2DiSdTBLu2YYOrzuH7wbTBBhNs1-KuwouLm4RiP-Rh0wOeY9vivja-MZ_wCuodFjq8ujrFRddvcDs0OThs2hLPP8_wdVJAXceroQ2v0cvK1B7ejOsU_Tj7cj1fJMtv5xfz02VSCJLyRAhJq7KSBkwJkOWkkjNKZZqmXEJO8jJLGZGcs6ICxQ3nPM1KbmakynguiOBTlOx8_QP0Q657ZxvjNrozVo-lu7gDLZSSbBZ59Szfu67cix6FNOOMKhKVH3bKiN0P4INurN8ObFroBq-lEpEU6X9BRtIYZbZ1_LgDC9d576B6eg0lepu_jvnrf_lH9t1oOuQNlHtyDDwC70fA-MLUVUy9sH7PKSEojbNM0cmOe7A1bJ7vqL9e3jy2Hr_Y-gC_nxTG3cWZuRL659W5Vstf8-8LeaYv-V-Ls9iT |
CODEN | JMVIDB |
CitedBy_id | crossref_primary_10_1128_JCM_00235_17 crossref_primary_10_1097_QAI_0b013e3181b05f62 crossref_primary_10_1016_j_jviromet_2007_06_019 crossref_primary_10_1155_2014_102598 crossref_primary_10_1097_QAI_0b013e318074eeca crossref_primary_10_1097_QAI_0b013e3181b9e726 crossref_primary_10_1136_bmjopen_2015_008795 crossref_primary_10_1016_j_jviromet_2018_04_005 crossref_primary_10_1016_j_jcv_2009_10_001 |
Cites_doi | 10.1128/JCM.38.11.4034-4041.2000 10.1007/s100960050273 10.1086/319752 10.1097/00002030-199907300-00006 10.1128/JCM.43.2.857-861.2005 10.2174/1570162053506955 10.7326/0003-4819-126-12-199706150-00003 10.1086/341490 10.1097/00126334-200212150-00006 10.1097/00002030-199707000-00004 10.1002/(SICI)1096-9071(199910)59:2<189::AID-JMV10>3.0.CO;2-A 10.1126/science.272.5265.1167 10.1002/jmv.20360 10.1097/00042560-199802010-00008 10.1097/00126334-200407010-00011 10.1089/088922299311556 10.1097/00002030-200302140-00006 10.1089/08892220050195865 10.1097/00002030-199702000-00010 10.1089/aid.1997.13.1071 10.1086/315253 10.1128/JCM.42.4.1534-1541.2004 10.1002/jmv.10492 10.1097/00002030-200002180-00011 10.1086/375369 10.1002/jmv.20071 10.1097/00126334-200208150-00001 10.1056/NEJM199602153340703 10.1097/00002030-200311210-00016 10.1097/00002030-199706000-00002 |
ContentType | Journal Article |
Copyright | Copyright © 2005 Wiley‐Liss, Inc. 2006 INIST-CNRS Copyright 2005 Wiley-Liss, Inc. |
Copyright_xml | – notice: Copyright © 2005 Wiley‐Liss, Inc. – notice: 2006 INIST-CNRS – notice: Copyright 2005 Wiley-Liss, Inc. |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TM 7U9 H94 7X8 ADTPV AOWAS |
DOI | 10.1002/jmv.20523 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic SwePub SwePub Articles |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9071 |
EndPage | 168 |
ExternalDocumentID | oai_swepub_ki_se_577624 oai_prod_swepub_kib_ki_se_1932170 10_1002_jmv_20523 16372295 17551119 JMV20523 ark_67375_WNG_7LXCSH6F_M |
Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GeographicLocations | Ethiopia Africa |
GeographicLocations_xml | – name: Ethiopia |
GrantInformation_xml | – fundername: Swedish Physicians against AIDS Research – fundername: ENARP (The Netherlands Ministry of Foreign Affairs and the Ethiopian Ministry of Health) |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT 08R AAUGY AAVGM ABHUG ACXME ADAWD ADDAD AFVGU AGJLS IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TM 7U9 H94 7X8 ADTPV AOWAS |
ID | FETCH-LOGICAL-c5083-5561fdf6aeadee9b0f6411688836eb0bd98206332cfe73a33389d3a40f93b5053 |
IEDL.DBID | 33P |
ISSN | 0146-6615 |
IngestDate | Tue Nov 12 03:39:13 EST 2024 Wed Oct 30 05:01:39 EDT 2024 Fri Aug 16 21:03:28 EDT 2024 Fri Aug 16 20:50:03 EDT 2024 Fri Aug 23 00:17:47 EDT 2024 Sat Sep 28 07:51:29 EDT 2024 Sun Oct 22 16:04:30 EDT 2023 Sat Aug 24 00:55:41 EDT 2024 Wed Oct 30 09:49:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | RNA-directed DNA polymerase HIV-1 virus Enzyme Copy number reverse transcriptase Transferases Retroviridae Lentivirus Virus Nucleotidyltransferases HIV-1 subtype C enzyme activity T-Lymphocyte Human immunodeficiency virus Viral load Subtype CD4 T-cell count Ethiopia Quantitative analysis |
Language | English |
License | CC BY 4.0 Copyright 2005 Wiley-Liss, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5083-5561fdf6aeadee9b0f6411688836eb0bd98206332cfe73a33389d3a40f93b5053 |
Notes | Swedish Physicians against AIDS Research ark:/67375/WNG-7LXCSH6F-M istex:1E17F102B75B3C28AC284D04D0E4433948A27979 ENARP (The Netherlands Ministry of Foreign Affairs and the Ethiopian Ministry of Health) ArticleID:JMV20523 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16372295 |
PQID | 20809690 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | swepub_primary_oai_swepub_ki_se_577624 swepub_primary_oai_prod_swepub_kib_ki_se_1932170 proquest_miscellaneous_67593258 proquest_miscellaneous_20809690 crossref_primary_10_1002_jmv_20523 pubmed_primary_16372295 pascalfrancis_primary_17551119 wiley_primary_10_1002_jmv_20523_JMV20523 istex_primary_ark_67375_WNG_7LXCSH6F_M |
PublicationCentury | 2000 |
PublicationDate | February 2006 |
PublicationDateYYYYMMDD | 2006-02-01 |
PublicationDate_xml | – month: 02 year: 2006 text: February 2006 |
PublicationDecade | 2000 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: New York, NY – name: United States |
PublicationTitle | Journal of medical virology |
PublicationTitleAlternate | J. Med. Virol |
PublicationYear | 2006 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Liss |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Liss |
References | Crowe S, Turnbull S, Oelrichs R, Dunne A. 2003. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis 37: S25-35. Wolday D, Tsegaye A, Messele T. 2002. Low absolute CD4 counts in Ethiopians. Ethiop Med J 40: 11-16. Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G, Schuitemaker H, Fontanet AL, Rinke de Wit TF. 1999. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. Aids 13: 1305-1311. Rinke de Wit TF, Tsegaye A, Wolday D, Hailu B, Aklilu M, Sanders E, Hagos M, Kliphuis A, Pollakis G, Krol A, Geskus R, Miedema F, Goudsmit J, Coutinho R, Fontanet AL. 2002. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr 30: 463-470. Ayele W, Pollakis G, Abebe A, Fisseha B, Tegbaru B, Tesfaye G, Mengistu Y, Wolday D, van Gemen B, Goudsmit J, Dorigo-Zetsma W, de Baar MP. 2004. Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C′ infections in Ethiopia. J Clin Microbiol 42: 1534-1541. Alaeus A, Leitner T, Lidman K, Albert J. 1997a. Most HIV-1 genetic subtypes have entered Sweden. AIDS 11: 199-202. Janssens W, Buve A, Nkengasong JN. 1997. The puzzle of HIV-1 subtypes in Africa. Aids 11: 705-712. Stevens G, Rekhviashvili N, Scott LE, Gonin R, Stevens W. 2005. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa. J Clin Microbiol 43: 857-861. Alaeus A, Lidman K, Sönnerborg A, Albert J. 1997b. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11: 859-865. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170. Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE. 2003. Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort. AIDS 17: 2521-2527. Greengrass VL, Turnball SP, Hocking J, Dunne AL, Tachedjian G, Corrigan GE, Crowe SM. 2005. Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Curr HIV Res 3: 183-190. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J. 2000. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 38: 4034-4041. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, Simon F. 2000. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS 14: 289-296. Abebe A, Pollakis G, Fontanet AL, Fisseha B, Tegbaru B, Kliphuis A, Tesfaye G, Negassa H, Cornelissen M, Goudsmit J, Rinke de Wit TF. 2000. Identification of a genetic subcluster of HIV type 1 subtype C (C′) widespread in Ethiopia. AIDS Res Hum Retroviruses 16: 1909-1914. Malmsten A, Shao XW, Sjödahl S, Fredriksson EL, Pettersson I, Leitner T, Källander CF, Sandström E, Gronowitz JS. 2005. Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 76: 291-296. Hoesley CJ, Allen SA, Raper JL, Musonda R, Niu Y, Gao F, Squires KE, Aldrovandi GM. 2002. Comparative analysis of commercial assays for the detection and quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma from patients infected with HIV-1 subtype C. Clin Infect Dis 35: 323-325. Braun J, Plantier JC, Hellot MF, Tuaillon E, Gueudin M, Damond F, Malmsten A, Corrigan GE, Simon F. 2003. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 17: 331-336. Sahlu T, Fontanet A, Rinke de Wit T, Messele T, Doorly R, Yeneneh H, Bindels P, Coutinho R. 1998. Identification of a site for a cohort study on natural history of HIV infection in Ethiopia. J Acquir Immune Defic Syndr Hum Retrovirol 17: 149-155. Holguin A, Rodes B, Dietrich U, Soriano V. 1999b. Human immunodeficiency viruses type 1 subtypes circulating in Spain. J Med Virol 59: 189-193. Abebe A, Kuiken CL, Goudsmit J, Valk M, Messele T, Sahlu T, Yeneneh H, Fontanet A, De Wolf F, Rinke de Wit TF. 1997. HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Hum Retroviruses 13: 1071-1075. Achkar JM, Burda ST, Konings FA, Urbanski MM, Williams CA, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN. 2004. Infection with HIV type 1 group M non-B subtypes in individuals living in New York City. J Acquir Immune Defic Syndr 36: 835-844. Malmsten A, Shao XW, Aperia K, Corrigan GE, Sandström E, Källander CF, Leitner T, Gronowitz JS. 2003. HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 71: 347-359. O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD. 1996. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 334: 426-431. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR Jr. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126: 946-954. Holguin A, de Mendoza C, Soriano V. 1999a. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes. Eur J Clin Microbiol Infect Dis 18: 256-259. Gottesman BS, Grosman Z, Lorber M, Levi I, Shitrit P, Mileguir F, Gottesman G, Chowers MY. 2004. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J Med Virol 73: 167-171. Jenny-Avital ER, Beatrice ST. 2001. Erroneously low or undetectable plasma human immunodeficiency virus type 1 (HIV-1) ribonucleic acid load, determined by polymerase chain reaction, in West African and American patients with non-B subtype HIV-1 infection. Clin Infect Dis 32: 1227-1230. Weidle PJ, Ganea CE, Irwin KL, Pieniazek D, McGowan JP, Olivo N, Ramos A, Schable C, Lal RB, Holmberg SD, Ernst JA. 2000. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis 181: 470-475. Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R. 1999. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res Hum Retroviruses 15: 133-142. Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. 2002. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr 31: 488-494. 1999b; 59 2004; 42 2002; 30 2002; 31 1997a; 11 2002; 35 2003; 37 2005; 43 2003; 17 2003; 71 1997b; 11 1997; 126 1998; 17 2004; 73 2000; 16 2000; 38 2000; 14 1997; 11 2000 2002; 40 2004; 36 1997; 13 1999; 15 1999; 13 1999a; 18 1996; 272 2005; 76 2005; 3 1996; 334 2001; 32 2000; 181 Holguin (10.1002/jmv.20523-BIB17) 1999a; 18 Abebe (10.1002/jmv.20523-BIB1) 2000 Weidle (10.1002/jmv.20523-BIB31) 2000; 181 Rinke de Wit (10.1002/jmv.20523-BIB28) 2002; 30 Mellors (10.1002/jmv.20523-BIB24) 1997; 126 Alaeus (10.1002/jmv.20523-BIB7) 1997b; 11 Stevens (10.1002/jmv.20523-BIB30) 2005; 43 Greengrass (10.1002/jmv.20523-BIB15) 2005; 3 Crowe (10.1002/jmv.20523-BIB13) 2003; 37 Wolday (10.1002/jmv.20523-BIB32) 2002; 40 Abebe (10.1002/jmv.20523-BIB4) 2000; 16 Amendola (10.1002/jmv.20523-BIB8) 2002; 31 Murphy (10.1002/jmv.20523-BIB25) 2000; 38 Malmsten (10.1002/jmv.20523-BIB21) 2003; 71 O'Brien (10.1002/jmv.20523-BIB26) 1996; 334 Parekh (10.1002/jmv.20523-BIB27) 1999; 15 Ayele (10.1002/jmv.20523-BIB9) 2004; 42 Holguin (10.1002/jmv.20523-BIB18) 1999b; 59 Hoesley (10.1002/jmv.20523-BIB16) 2002; 35 Janssens (10.1002/jmv.20523-BIB19) 1997; 11 Malmsten (10.1002/jmv.20523-BIB22) 2005; 76 Abebe (10.1002/jmv.20523-BIB3) 1999; 13 Alaeus (10.1002/jmv.20523-BIB6) 1997a; 11 Sahlu (10.1002/jmv.20523-BIB29) 1998; 17 Achkar (10.1002/jmv.20523-BIB5) 2004; 36 Couturier (10.1002/jmv.20523-BIB12) 2000; 14 Abebe (10.1002/jmv.20523-BIB2) 1997; 13 Braun (10.1002/jmv.20523-BIB10) 2003; 17 Jenny-Avital (10.1002/jmv.20523-BIB20) 2001; 32 Mellors (10.1002/jmv.20523-BIB23) 1996; 272 Gottesman (10.1002/jmv.20523-BIB14) 2004; 73 Brodine (10.1002/jmv.20523-BIB11) 2003; 17 |
References_xml | – volume: 42 start-page: 1534 year: 2004 end-page: 1541 article-title: Development of a nucleic acid sequence‐based amplification assay that uses gag‐based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C′ infections in Ethiopia publication-title: J Clin Microbiol – volume: 18 start-page: 256 year: 1999a end-page: 259 article-title: Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non‐B HIV‐1 subtypes publication-title: Eur J Clin Microbiol Infect Dis – volume: 32 start-page: 1227 year: 2001 end-page: 1230 article-title: Erroneously low or undetectable plasma human immunodeficiency virus type 1 (HIV‐1) ribonucleic acid load, determined by polymerase chain reaction, in West African and American patients with non‐B subtype HIV‐1 infection publication-title: Clin Infect Dis – volume: 43 start-page: 857 year: 2005 end-page: 861 article-title: Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C‐infected patients from South Africa publication-title: J Clin Microbiol – volume: 31 start-page: 488 year: 2002 end-page: 494 article-title: Underevaluation of HIV‐1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV‐1 A/G circulating recombinant form (CRF02) publication-title: J Acquir Immune Defic Syndr – volume: 11 start-page: 705 year: 1997 end-page: 712 article-title: The puzzle of HIV‐1 subtypes in Africa publication-title: Aids – volume: 76 start-page: 291 year: 2005 end-page: 296 article-title: Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma publication-title: J Med Virol – volume: 181 start-page: 470 year: 2000 end-page: 475 article-title: Presence of human immunodeficiency virus (HIV) type 1, group M, non‐B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States publication-title: J Infect Dis – volume: 73 start-page: 167 year: 2004 end-page: 171 article-title: Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load publication-title: J Med Virol – year: 2000 – volume: 71 start-page: 347 year: 2003 end-page: 359 article-title: HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma publication-title: J Med Virol – volume: 14 start-page: 289 year: 2000 end-page: 296 article-title: HIV‐1 diversity in France, 1996‐1998. The AC 11 laboratory network publication-title: AIDS – volume: 334 start-page: 426 year: 1996 end-page: 431 article-title: Changes in plasma HIV‐1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS publication-title: N Engl J Med – volume: 30 start-page: 463 year: 2002 end-page: 470 article-title: Primary HIV‐1 subtype C infection in Ethiopia publication-title: J Acquir Immune Defic Syndr – volume: 272 start-page: 1167 year: 1996 end-page: 1170 article-title: Prognosis in HIV‐1 infection predicted by the quantity of virus in plasma publication-title: Science – volume: 11 start-page: 859 year: 1997b end-page: 865 article-title: Subtype‐specific problems with quantification of plasma HIV‐1 RNA publication-title: AIDS – volume: 36 start-page: 835 year: 2004 end-page: 844 article-title: Infection with HIV type 1 group M non‐B subtypes in individuals living in New York City publication-title: J Acquir Immune Defic Syndr – volume: 59 start-page: 189 year: 1999b end-page: 193 article-title: Human immunodeficiency viruses type 1 subtypes circulating in Spain publication-title: J Med Virol – volume: 126 start-page: 946 year: 1997 end-page: 954 article-title: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV‐1 infection publication-title: Ann Intern Med – volume: 17 start-page: 2521 year: 2003 end-page: 2527 article-title: Diverse HIV‐1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort publication-title: AIDS – volume: 13 start-page: 1305 year: 1999 end-page: 1311 article-title: HIV‐1 subtype C syncytium‐ and non‐syncytium‐inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS publication-title: Aids – volume: 38 start-page: 4034 year: 2000 end-page: 4041 article-title: Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma publication-title: J Clin Microbiol – volume: 13 start-page: 1071 year: 1997 end-page: 1075 article-title: HIV type 1 subtype C in Addis Ababa, Ethiopia publication-title: AIDS Res Hum Retroviruses – volume: 3 start-page: 183 year: 2005 end-page: 190 article-title: Evaluation of a low cost reverse transcriptase assay for plasma HIV‐1 viral load monitoring publication-title: Curr HIV Res – volume: 35 start-page: 323 year: 2002 end-page: 325 article-title: Comparative analysis of commercial assays for the detection and quantification of human immunodeficiency virus type 1 (HIV‐1) RNA in plasma from patients infected with HIV‐1 subtype C publication-title: Clin Infect Dis – volume: 16 start-page: 1909 year: 2000 end-page: 1914 article-title: Identification of a genetic subcluster of HIV type 1 subtype C (C′) widespread in Ethiopia publication-title: AIDS Res Hum Retroviruses – volume: 40 start-page: 11 year: 2002 end-page: 16 article-title: Low absolute CD4 counts in Ethiopians publication-title: Ethiop Med J – volume: 37 start-page: S25 year: 2003 end-page: 35 article-title: Monitoring of human immunodeficiency virus infection in resource‐constrained countries publication-title: Clin Infect Dis – volume: 11 start-page: 199 year: 1997a end-page: 202 article-title: Most HIV‐1 genetic subtypes have entered Sweden publication-title: AIDS – volume: 15 start-page: 133 year: 1999 end-page: 142 article-title: Impact of HIV type 1 subtype variation on viral RNA quantitation publication-title: AIDS Res Hum Retroviruses – volume: 17 start-page: 149 year: 1998 end-page: 155 article-title: Identification of a site for a cohort study on natural history of HIV infection in Ethiopia publication-title: J Acquir Immune Defic Syndr Hum Retrovirol – volume: 17 start-page: 331 year: 2003 end-page: 336 article-title: A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes publication-title: AIDS – volume: 38 start-page: 4034 year: 2000 ident: 10.1002/jmv.20523-BIB25 publication-title: J Clin Microbiol doi: 10.1128/JCM.38.11.4034-4041.2000 contributor: fullname: Murphy – volume: 18 start-page: 256 year: 1999a ident: 10.1002/jmv.20523-BIB17 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s100960050273 contributor: fullname: Holguin – volume: 32 start-page: 1227 year: 2001 ident: 10.1002/jmv.20523-BIB20 publication-title: Clin Infect Dis doi: 10.1086/319752 contributor: fullname: Jenny-Avital – volume: 13 start-page: 1305 year: 1999 ident: 10.1002/jmv.20523-BIB3 publication-title: Aids doi: 10.1097/00002030-199907300-00006 contributor: fullname: Abebe – volume: 43 start-page: 857 year: 2005 ident: 10.1002/jmv.20523-BIB30 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.2.857-861.2005 contributor: fullname: Stevens – volume: 3 start-page: 183 year: 2005 ident: 10.1002/jmv.20523-BIB15 publication-title: Curr HIV Res doi: 10.2174/1570162053506955 contributor: fullname: Greengrass – volume: 126 start-page: 946 year: 1997 ident: 10.1002/jmv.20523-BIB24 publication-title: Ann Intern Med doi: 10.7326/0003-4819-126-12-199706150-00003 contributor: fullname: Mellors – volume: 35 start-page: 323 year: 2002 ident: 10.1002/jmv.20523-BIB16 publication-title: Clin Infect Dis doi: 10.1086/341490 contributor: fullname: Hoesley – volume: 31 start-page: 488 year: 2002 ident: 10.1002/jmv.20523-BIB8 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200212150-00006 contributor: fullname: Amendola – volume: 11 start-page: 859 year: 1997b ident: 10.1002/jmv.20523-BIB7 publication-title: AIDS doi: 10.1097/00002030-199707000-00004 contributor: fullname: Alaeus – volume: 59 start-page: 189 year: 1999b ident: 10.1002/jmv.20523-BIB18 publication-title: J Med Virol doi: 10.1002/(SICI)1096-9071(199910)59:2<189::AID-JMV10>3.0.CO;2-A contributor: fullname: Holguin – volume: 272 start-page: 1167 year: 1996 ident: 10.1002/jmv.20523-BIB23 publication-title: Science doi: 10.1126/science.272.5265.1167 contributor: fullname: Mellors – volume: 76 start-page: 291 year: 2005 ident: 10.1002/jmv.20523-BIB22 publication-title: J Med Virol doi: 10.1002/jmv.20360 contributor: fullname: Malmsten – volume: 17 start-page: 149 year: 1998 ident: 10.1002/jmv.20523-BIB29 publication-title: J Acquir Immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199802010-00008 contributor: fullname: Sahlu – year: 2000 ident: 10.1002/jmv.20523-BIB1 contributor: fullname: Abebe – volume: 40 start-page: 11 year: 2002 ident: 10.1002/jmv.20523-BIB32 publication-title: Ethiop Med J contributor: fullname: Wolday – volume: 36 start-page: 835 year: 2004 ident: 10.1002/jmv.20523-BIB5 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200407010-00011 contributor: fullname: Achkar – volume: 15 start-page: 133 year: 1999 ident: 10.1002/jmv.20523-BIB27 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/088922299311556 contributor: fullname: Parekh – volume: 17 start-page: 331 year: 2003 ident: 10.1002/jmv.20523-BIB10 publication-title: AIDS doi: 10.1097/00002030-200302140-00006 contributor: fullname: Braun – volume: 16 start-page: 1909 year: 2000 ident: 10.1002/jmv.20523-BIB4 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/08892220050195865 contributor: fullname: Abebe – volume: 11 start-page: 199 year: 1997a ident: 10.1002/jmv.20523-BIB6 publication-title: AIDS doi: 10.1097/00002030-199702000-00010 contributor: fullname: Alaeus – volume: 13 start-page: 1071 year: 1997 ident: 10.1002/jmv.20523-BIB2 publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.1997.13.1071 contributor: fullname: Abebe – volume: 181 start-page: 470 year: 2000 ident: 10.1002/jmv.20523-BIB31 publication-title: J Infect Dis doi: 10.1086/315253 contributor: fullname: Weidle – volume: 42 start-page: 1534 year: 2004 ident: 10.1002/jmv.20523-BIB9 publication-title: J Clin Microbiol doi: 10.1128/JCM.42.4.1534-1541.2004 contributor: fullname: Ayele – volume: 71 start-page: 347 year: 2003 ident: 10.1002/jmv.20523-BIB21 publication-title: J Med Virol doi: 10.1002/jmv.10492 contributor: fullname: Malmsten – volume: 14 start-page: 289 year: 2000 ident: 10.1002/jmv.20523-BIB12 publication-title: AIDS doi: 10.1097/00002030-200002180-00011 contributor: fullname: Couturier – volume: 37 start-page: s25 year: 2003 ident: 10.1002/jmv.20523-BIB13 publication-title: Clin Infect Dis doi: 10.1086/375369 contributor: fullname: Crowe – volume: 73 start-page: 167 year: 2004 ident: 10.1002/jmv.20523-BIB14 publication-title: J Med Virol doi: 10.1002/jmv.20071 contributor: fullname: Gottesman – volume: 30 start-page: 463 year: 2002 ident: 10.1002/jmv.20523-BIB28 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200208150-00001 contributor: fullname: Rinke de Wit – volume: 334 start-page: 426 year: 1996 ident: 10.1002/jmv.20523-BIB26 publication-title: N Engl J Med doi: 10.1056/NEJM199602153340703 contributor: fullname: O'Brien – volume: 17 start-page: 2521 year: 2003 ident: 10.1002/jmv.20523-BIB11 publication-title: AIDS doi: 10.1097/00002030-200311210-00016 contributor: fullname: Brodine – volume: 11 start-page: 705 year: 1997 ident: 10.1002/jmv.20523-BIB19 publication-title: Aids doi: 10.1097/00002030-199706000-00002 contributor: fullname: Janssens |
SSID | ssj0008922 |
Score | 1.8921268 |
Snippet | The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV‐1 RNA based assay,... The present study monitored the changes in human immunodeficiency virus (HIV) viral load using a reverse transcriptase (RT) assay and an HIV-1 RNA based assay,... |
SourceID | swepub proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 161 |
SubjectTerms | Biological and medical sciences CD4 Lymphocyte Count CD4 T-cell count enzyme activity Ethiopia Fundamental and applied biological sciences. Psychology HIV Infections - immunology HIV Infections - metabolism HIV Infections - virology HIV Reverse Transcriptase - blood HIV-1 - genetics HIV-1 - isolation & purification HIV-1 - metabolism HIV-1 subtype C Human immunodeficiency virus 1 Human viral diseases Humans Infectious diseases Medical sciences Medicin och hälsovetenskap Microbiology Miscellaneous Prospective Studies reverse transcriptase RNA, Viral - blood Viral diseases Viral Load Virology |
Title | Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count |
URI | https://api.istex.fr/ark:/67375/WNG-7LXCSH6F-M/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.20523 https://www.ncbi.nlm.nih.gov/pubmed/16372295 https://search.proquest.com/docview/20809690 https://search.proquest.com/docview/67593258 http://kipublications.ki.se/Default.aspx?queryparsed=id:1932170 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSIgL70d4lBFCFZeoTpzECZyqbZcFsSvUltKb5WxsqVRNlmaD4Ib4BfxGfgkzcZLVSq2ExCFSlIxjZTyehz3-hrGXaZLJwqSRz4XI_SiPEj81QvuJ5LYw2po4oIPCkwM5O0539wgm501_FsbhQwwLbjQzWn1NE1zn9fYKNPTL2TcM7zCOQv2LUUJ7fEN8HLRwmrkdBNQEPtqguEcV4uH20HLNFl0jtn6n3EhdI3usq2txkeM5oIquO7StRRrf-q9_uc1udo4o7DjJucOumPIuuz7tttrvsV_7hjI2DCzJmrW6BQ0e0DkIKjcB6OzC10aXyw7kGyoLk3dHf37-DqBuclrahRGclLBA__xMv4Y-7Q6WFezPdmBeLX6AK0gCuixgtBvBITanrQRoS1jcZ5_Ge4ejid8VbPDnhCrvU6lNW9hEUxa2yXJukygIEgyyRWJynhcZocULEc6tkUILDI-zQuiI20zk6IqJB2yjrErziME8RkHRAddhYCMtcp2hrTWhDWXORcFDj73oh04tHC6HcgjMoUJuqpabHttqB3Wg0OenlMgmY_V59lbJD8ejg0kyVlOPba6N-uqTEj3KIMg89rwXA4XzjzihS1M1NXaUYhSY8cspMCRDJzlOPfbQyc_q64mQVE7dY9wJ1PCGQL_Jgqru-ekJXao2ihzuQGJ3Wxc0GaiJMpZo6CKPvWol73IuqffTo_bm8b-TPmE33FoU5fU8ZRvL88Y8Y1frotlsp-Ff_CE3pA |
link.rule.ids | 230,315,782,786,887,1408,27935,27936,46066,46490 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB6aBNpe-n6oj2QoJfQistJKWqn0Epy4TmubkrhJbsvK2oU0RHZju7S30l_Q39hf0hnJljEkUOhBYORZCc3O7nyzO_sNwOs0yVRh08gXUuZ-lEeJn1pp_EQJV1jjbBzwQeHOkeqfpnv7TJPzbnEWpuaHaBbceGRU8zUPcF6Q3lmyhn65-EbxHQVSa7ARJVHGhRuk_NTMw2lW7yHQXOCTF4oXvEIi3GmarnijDVbsd86ONBNSkKsrW1wFPRte0VVIW_mk9t3_-5p7cGeORXG3Np77cMOWD-Bmb77b_hB-HVpO2rA4ZYdWTS_k85CPQnDFCSS8i19nppzOeb5x5LBzcPzn5-8AJ7OcV3exhWcljgmiX5i3uMi8w-kID_u7OByNf2BdkwRNWWBrL8IBNefdBKyqWDyCz-39Qavjz2s2-EMmlve52qYrXGI4EdtmuXBJFAQJxdkysbnIi4wJ46UMh84qaSRFyFkhTSRcJnNCY_IxrJej0j4FHMZkKyYQJgxcZGRuMnK3NnShyoUsROjBq0Xf6XFNzaFrEuZQkzZ1pU0PtqtebSTM5TnnsqlYn_Tfa9U9bR11krbuebC50u3LRyoClUGQebC1sANNQ5A1YUo7mk3oRSkFgpm4XoKiMsLJcerBk9qAlk9PpOKK6h6I2qKaf5j3m52ont8_P-NLT6xmzB0oet32FU0aaZaMFfm6yIM3leldryX9oXdc_Xj276JbcKsz6HV196D_8TncrpemOM3nBaxPL2f2JaxNitlmNSb_AmC_O8U |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fa9swED_WFspe9v-Pu609xih7MZUt27K3p5I0S7cmlLbr-ibkWIKu1EmbZGxvY59gn3GfZHd24hBoYbAHQ3BONj6ddL-TTr8DeJMmmSpsGvlCytyP8ijxUyuNnyjhCmucjQM-KNw9Vv2ztL3HNDnv52dhan6IZsGNR0Y1X_MAHxVuZ0Ea-vXyG4V3FEetwFrEMJzPb8jDZhpOs3oLgaYCn5xQPKcVEuFO03TJGa2xXr9zcqQZk35cXdjiJuTZ0IouI9rKJXXu_9fHPIB7MySKu7XpPIQ7tnwE673ZXvtj-HVkOWXD4oTdWTW5kMdDPgjB9SaQ0C5eTU05mbF849Bhd__0z8_fAY6nOa_tYgvPSxwRQL8073Ced4eTIR71d3EwHP3AuiIJmrLAVjvCE2rOewlY1bB4Ap87eyetrj-r2OAPmFbe51qbrnCJ4TRsm-XCJVEQJBRly8TmIi8ypouXMhw4q6SRFB9nhTSRcJnMCYvJp7BaDkv7HHAQk6WYQJgwcJGRucnI2drQhSoXshChB6_nXadHNTGHrimYQ03a1JU2PdiuOrWRMNcXnMmmYv2l_0Grg7PWcTfp6J4Hm0u9vnikIkgZBJkHW3Mz0DQAWROmtMPpmF6UUhiYidslKCYjlBynHjyr7Wfx9EQqrqfugagNqvmHWb_ZherZ_YtzvvTYakbcgaLXbd_QpJFmyViRp4s8eFtZ3u1a0h97p9WPjX8X3YL1w3ZHH-z3P72Au_W6FOf4vITVyfXUvoKVcTHdrEbkX4csOnQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reverse+transcriptase+activity+for+quantitation+of+HIV%E2%80%901+subtype+C+in+plasma%3A+Relation+to+RNA+copy+number+and+CD4+T%E2%80%90cell+count&rft.jtitle=Journal+of+medical+virology&rft.au=Seyoum%2C+Elizabeth&rft.au=Wolday%2C+Dawit&rft.au=Girma%2C+Mulu&rft.au=Malmsten%2C+Anders&rft.date=2006-02-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=78&rft.issue=2&rft.spage=161&rft.epage=168&rft_id=info:doi/10.1002%2Fjmv.20523&rft.externalDBID=10.1002%252Fjmv.20523&rft.externalDocID=JMV20523 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |